Particulars (in Rs. Cr) | Q4FY25 | Q4FY24 | YoY (%) | Q3FY25 | QoQ (%) |
---|---|---|---|---|---|
Revenues in INR | 3410.00 | 2318.00 | 47.00% | 3258.00 | 5.00% |
EBITDA | 575.00 | 423.00 | 36.00% | 506.00 | 14.00% |
EBITDA Margin (%) | 16.90% | 18.30% | (140 bps) | 15.50% | 140 bps |
Net profit | 307.00 | 229.00 | 34.00% | 256.00 | 20.00% |
EPS (Rs.) | 38.67 | 36.10 | 7.00% | 31.94 | 21.00% |
Source: Company Filings; stockaxis Research
Q4FY25 Result Highlights
Coforge delivered another resilient financial performance for the quarter ended
Q4FY25. On consolidated basis, Coforge reported revenue of $410.2 million, up 3.4%
QoQ/43.8% y-o-y in constant currency (cc) terms. Revenue in rupee terms stood at
Rs.3,469.1 crores, up 4.5% QoQ/47.1% YoY. Revenue from continuing business stood
at $403.5, up 3.3% QoQ/43.6% YoY. For FY25 revenue from continuing business stood
at $ 1,445.2 million, up 31.5% YoY. Sequential growth was led by BFS, TTH and Government
verticals. EBITDA margins from continuing business improved ~134 bps QoQ to 16.9%
while Adj. EBITDA Margin improved ~100 bps QoQ to 18.7%. ESOP costs have come down
by 33 basis point and now stands at 1.8% and is expected to come down to a level
of 100 basis point from H2FY26. Adjusted PAT stood at Rs 287.3 crores, up 24.1%
QoQ/22.2% YoY.
The company reported the highest fresh order intake of $2.1 billion compared to $501 million in Q3FY25 and signed five large deals during the quarter. Executable order book over next 12 months stood at $1,505 million, up 10.3% QoQ/47.7% YoY. Net headcount increased by 403 QoQ, taking the total headcount to 33,497. LTM attrition stood at 10.9%, down 100 bps QoQ. Utilisation (including Trainees) improved 70bps QoQ to 82%.
The number of clients in $ 5-10 million category increased by 4, while the number of clients in $ 1-5 million category declined by 3. Revenue from Top 5 and Top 10 client declined 6.1% and 4.6% QoQ, respectively.
The BFS, TTH and Government grew 13.4%/ 7.5% and 8.5% QoQ respectively while Other emerging vertical declined 8.3% QoQ, respectively, in US Dollar terms. The Sabre $1.56 billion deal has seen an impeccable transition and ramp-up is on track. Management does not see any margin dilution due to the deal.
Coforge signed a definitive agreement to sell its entire stake in the Advantage Go business for GBP 43 million. Advantage Go generated $23 million in revenue, a $5 million EBIT loss, and an $8.5 million cash burn in FY25.
Q4 FY25 - Key Business Highlights
Recognitions
Partnerships
FY25 Highlights
Demand Outlook
Guidance
Deal Pipeline and orderbook
Other Key Highlights
Coforge reported steady financial performance for the quarter ended Q4FY25. We believe the company is well placed to see robust and sustained growth in the quarters ahead given the strengthening of order book, strong large deal pipeline, and consecutive quarters of significant net headcount additions and on account of synergies with Cigniti picking up momentum. The management stated that the merger with Cigniti would help the company to drive operational margin improvement as EBITDA margin of Cigniti has improved from 12%. Further, a strategic focus on diversifying the business into emerging verticals, improvement in client metrics, strong executable orders, and sharp recovery in the travel segment would aid growth. The 12 month executable order book and fresh order intake witnessed a sharp jump during the quarter and provides strong visibility for the quarters ahead. Strong leadership, deep domain capability in select verticals, improved capability, and a marquee client base would help the company sustain growth momentum.
Strong growth, better digital mix, and operating efficiencies should drive margin expansion in the next two years. We believe the organic business is robust and is likely to regain its strong growth trajectory in coming quarters driven by recovery in key verticals especially BFS, ramp up of deal wins, and recovery of pent-up demand triggered by a better macro environment. The management remains optimistic on growth momentum sustaining in FY26, with reported EBIT margin expansion backed by broad-based growth, Sabre deal ramp up, integration of Rythmos/TMLabs, healthy deal pipeline. The company is confident of achieving USD 2 bn revenue by FY27, with 18% EBITDAM/~14% EBITM. At CMP of Rs.7460, the stock is trading at 30x FY27E. We maintain HOLD rating on the stock.
Particulars (in Rs. Cr) | Q4FY25 | Q4FY24 | YoY (%) | Q3FY25 | QoQ (%) |
---|---|---|---|---|---|
Revenues ($ mn) | 404.00 | 287.00 | 41.00% | 390.50 | 3.00% |
Revenues in INR | 3410.00 | 2318.00 | 47.00% | 3258.00 | 5.00% |
Expenses | 1996.00 | 1344.00 | 49.00% | 1957.00 | 2.00% |
Gross Profit | 1414.00 | 974.00 | 45.00% | 1301.00 | 9.00% |
Selling/G&A | 1352.00 | 529.00 | 156.00% | 726.00 | 86.00% |
Acquisition related to costs/ESOPs | 62.00 | 22.00 | 182.00% | 69.00 | -10.00% |
EBITDA | 575.00 | 423.00 | 36.00% | 506.00 | 14.00% |
EBITDA Margin (%) | 16.90% | 18.30% | (140 bps) | 15.50% | 140 bps |
Depreciation | 125.00 | 79.00 | 58.00% | 117.00 | 7.00% |
EBIT | 449.00 | 344.00 | 31.00% | 389.00 | 15.00% |
EBIT Margin (%) | 13.20% | 14.80% | (160 bps) | 11.90% | 130 bps |
Other Income | -30.00 | -45.00 | - | -33.00 | - |
PBT | 393.00 | 289.00 | 36.00% | 340.00 | 16.00% |
Tax provision | 87.00 | 59.00 | 47.00% | 87.00 | 0.00% |
Minority interest | 45.00 | 7.00 | 543.00% | 38.00 | 18.00% |
Net profit | 307.00 | 229.00 | 34.00% | 256.00 | 20.00% |
EPS (Rs.) | 38.67 | 36.10 | 7.00% | 31.94 | 21.00% |